HER2+ mBC: Safety and Tolerability in HER2CLIMB

Video

Related Videos
Samilia Obeng-Gyasi, MD, MPH,
Lauren E. Nye, MD
Debu Tripathy, MD
Nan Chen, MD
Debu Tripathy, MD
Timothy Yap, MBBS, PhD, FRCP
Parul N Barry, MD,
Erin Frances Cobain, MD
Erin Frances Cobain, MD
Debu Tripathy, MD
Related Content
Hope S. Rugo, MD

Capivasertib/Fulvestrant Improves PFS2 in Pretreated PIK3CA/AKT1/PTEN+ HR+/HER2– Breast Cancer

May 16th 2024
Article
OncLive On Air

Revisit the OncLive On Air Episodes From February 2024

March 18th 2024
Podcast
Mafalda Oliveira, MD, PhD

Ipatasertib/Anti-HER2 Therapy Is Safe and Active in PIK3CA-Mutant, HER2+ Advanced Breast Cancer

May 16th 2024
Article
Bradley J. Monk, MD, FACOG, FACS; Paolo Tarantino, MD

Monk and Tarantino Describe the Investigation of B7-H4 Vedotin–Directed ADCs in Gynecologic and Breast Cancers

January 11th 2024
Podcast
Erika Hamilton, MD

Vepdegestrant Plus Palbociclib Sustains Efficacy in Advanced ER+ Breast Cancer

May 16th 2024
Article
Carol M. Mangione, MD, of UCLA Health

Updated Breast Cancer Screening Recommendations Pave the Way for a More Equitable Future

May 16th 2024
Article